Accelerated Approval Pathway: Key Takeaways From Patient And Expert Panels
I recently participated in two panels hosted by Patients Rising Now about the Food and Drug Administration’s (FDA) Accelerated Approval Program, which allows for the earlier approval of drugs that treat serious conditions. As a life sciences consultant, a trained pharmacist, and a rare disease patient and advocate, I was honored to join health care experts and other […]
